The order of administration of trastuzumab to SN-38 infl uences SN-38's cytotoxicity in gastric cancer cell lines with or without HER2 expression

被引:0
|
作者
Yamade, M. [1 ]
Sugimoto, M. [1 ]
Nishino, M. [1 ]
Uotani, T. [1 ]
Sahara, S. [1 ]
Furuta, T. [2 ]
机构
[1] Hamamatsu Univ Sch Med, Dept Med 1, Hamamatsu, Shizuoka, Japan
[2] Hamamatsu Univ Sch Med, Clin Res Ctr, Hamamatsu, Shizuoka, Japan
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:46 / 47
页数:2
相关论文
共 50 条
  • [41] Topoisomerase I Inhibitor SN-38 Effectively Attenuates Growth of Human Non-Small-Cell Lung Cancer Cell Lines In Vitro and In Vivo
    Maurya, Dharmendra Kumar
    Ayuzawa, Rie
    Doi, Chiyo
    Troyer, Deryl
    Tamura, Masaaki
    JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY, 2011, 30 (01) : 1 - 10
  • [42] Angiocytotoxic therapy in human non-small cell lung cancer cell lines -: Advantage of combined effects of TNP-470 and SN-38
    Satoh, H
    Ishikawa, H
    Fujimoto, M
    Fujiwara, M
    Yamashita, YT
    Yazawa, T
    Ohtsuka, M
    Hasegawa, S
    Kamma, H
    ACTA ONCOLOGICA, 1998, 37 (01) : 85 - 90
  • [43] Pregnane × Receptor (PXR) expression in colorectal cancer cells restricts irinotecan chemosensitivity through enhanced SN-38 glucuronidation
    Caroline Raynal
    Jean-Marc Pascussi
    Géraldine Leguelinel
    Cyril Breuker
    Jovana Kantar
    Benjamin Lallemant
    Sylvain Poujol
    Caroline Bonnans
    Dominique Joubert
    Frédéric Hollande
    Serge Lumbroso
    Jean-Paul Brouillet
    Alexandre Evrard
    Molecular Cancer, 9
  • [44] Trastuzumab Has Opposing Effects on SN-38-Induced Double Strand Breaks and Cytotoxicity in HER2-Positive Gastric Cancer Cells Depending on Administration Sequence
    Yamade, Mihoko
    Sugimoto, Mitsushige
    Nishino, Masafumi
    Uotani, Takahiro
    Sahara, Shu
    Yamada, Takanori
    Osawa, Satoshi
    Sugimoto, Ken
    Furuta, Takahisa
    GASTROENTEROLOGY, 2012, 142 (05) : S327 - S327
  • [45] Combined effects of SN-38 and pentoxifylline on the induction of apoptosis through the activation of CPP-32 in pancreatic adenocarcinoma cell lines
    Shudo R.
    Ura H.
    Tanno S.
    Obara T.
    Kohgo Y.
    International Journal of Clinical Oncology, 1999, 4 (3) : 156 - 163
  • [46] In vitro schedule-dependent interaction between paclitaxel and SN-38 (the active metabolite of irinotecan) in human carcinoma cell lines
    Kano, Y
    Akutsu, M
    Tsunoda, S
    Mori, K
    Suzuki, K
    Adachi, KI
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1998, 42 (02) : 91 - 98
  • [47] In vitro schedule-dependent interaction between paclitaxel and SN-38 (the active metabolite of irinotecan) in human carcinoma cell lines
    Yasuhiko Kano
    Miyuki Akutsu
    Saburo Tsunoda
    Koyoshi Mori
    Kenichi Suzuki
    Ken-Ichi Adachi
    Cancer Chemotherapy and Pharmacology, 1998, 42 : 91 - 98
  • [48] Angiocytotoxic therapy in human non-small cell lung cancer cell lines. Advantage of combined effects of TNP-470 and SN-38
    Satoh, Hiroaki
    Ishikawa, Hiroichi
    Fujimoto, Mitsuo
    Fujiwara, Masachika
    Yamashita, Yuko T.
    Yazawa, Takuya
    Ohtsuka, Morio
    Hasegawa, Shizuo
    Kamma, Hiroshi
    Acta Oncologica, 37 (01): : 85 - 90
  • [49] Pregnane x Receptor (PXR) expression in colorectal cancer cells restricts irinotecan chemosensitivity through enhanced SN-38 glucuronidation
    Raynal, Caroline
    Pascussi, Jean-Marc
    Legueline, Geraldine
    Breuker, Cyril
    Kantar, Jovana
    Lallemant, Benjamin
    Poujol, Sylvain
    Bonnans, Caroline
    Joubert, Dominique
    Hollande, Frederic
    Lumbroso, Serge
    Brouillet, Jean-Paul
    Evrard, Alexandre
    MOLECULAR CANCER, 2010, 9
  • [50] Cytotoxicity of Pure Nanodrugs of SN-38 and Podophyllotoxin Dimers in Human Cancer HepG2, KPL-4, and MCF-7 Cells
    Koseki, Yoshitaka
    Ikuta, Yoshikazu
    Murakami, Tatsuya
    Onodera, Tsunenobu
    Oikawa, Hidetoshi
    Cong, Liman
    Tada, Hiroshi
    Gonda, Kohsuke
    Ohuchi, Noriaki
    Kasai, Hitoshi
    MOLECULAR CRYSTALS AND LIQUID CRYSTALS, 2015, 622 (01) : 1 - 5